Press release
Diabetic K*etoacidosis (DKA) Market Size Forecasted To Achieve 4.37 Billion By 2029 With Steady Growth
Diabetic K*etoacidosis (DKA)
What Is the Diabetic K*etoacidosis (DKA) Market Size and Projected Growth Rate?
In recent times, there has been a robust growth in the diabetic K*etoacidosis (DKA) market. The market is projected to grow from a worth of $2.90 billion in 2024 to approximately $3.16 billion by 2025, indicating a compound annual growth rate (CAGR) of 8.8%. The growth experienced in the historical time frame can be linked to factors such as the rise in diabetes cases, late diagnosis of type 1 diabetes, non-adherence to insulin treatment, increasing cases of obesity, and a deficiency in diabetes awareness programs.
The market size for diabetic K*etoacidosis (DKA) is predicted to witness robust growth in the forthcoming years, expanding to a valuation of $4.37 billion in 2029 with an 8.5% compound annual growth rate (CAGR). The growth forecasted for this period can be credited to improvements in insulin delivery mechanisms, the increasingly prevalent use of continuous glucose monitoring, heightened awareness about the complications associated with diabetes, the broadening scope of telemedicine in managing diabetes, and escalating healthcare costs. Foreseen trends in the forecast duration comprise the incorporation of artificial intelligence into diabetes treatment, the progression of closed-loop insulin delivery systems, personalized medical treatment, pioneering technologies, and innovative therapeutic approaches.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21168
What Are the Major Segments in the Diabetic K*etoacidosis (DKA) Market?
The diabetic K*etoacidosis (DKA) market covered in this report is segmented -
1) By Type: Pediatric Diabetic K*etoacidosis, Adult Diabetic K*etoacidosis
2) By Treatment Type: Fluid Replacement, Electrolyte Replacement, Insulin Therapy, Intermediate-Acting Insulin, Long-Acting Insulin
3) By Route of Administration: Oral, Parenteral, Other
4) By Distribution Channel: Online Channel, Offline Channel
5) By End Use: Hospitals, Ambulatory Care Center, Specialty Clinics
Subsegments:
1) By Pediatric Diabetic K*etoacidosis: Mild Pediatric DKA, Moderate Pediatric DKA, Severe Pediatric DKA
2) By Adult Diabetic K*etoacidosis: Mild Adult DKA, Moderate Adult DKA, Severe Adult DKA
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21168&type=smp
What Are The Driving Diabetic K*etoacidosis (DKA) Market Evolution?
The spike in obesity rates is propelling the growth of the diabetic K*etoacidosis (DKA) market. Defined as a health condition distinguished by the over-accumulation of body fat that could potentially harm health and promote various diseases, obesity is on an upward trajectory due to a host of factors. These include unhealthy diet rich in processed foods, sugars, and fats, inactive lifestyles with minimal physical movement, augmented screen time, and socio-economic elements like accessible and affordable health foods and medical care. The surge in obesity rates heightens the chances of developing DKA by enhancing insulin resistance and inducing type 2 diabetes, which may result in poor blood sugar management and consequently trigger DKA incidents. For instance, the World Health Organization (WHO), an intergovernmental organization based in Switzerland, revealed in March 2024 that nearly one in eight individuals globally were grappling with obesity. This statistic included 2.5 billion adults (from the age of 18 years) who were overweight, of which 890 million battled obesity. Of the adult population, 43% were overweight, and 16% fell in the obese category. Moreover, the count of overweight children aged below 5 escalated to 37 million. Hence, the escalating prevalence of obesity propels the growth of the diabetic K*etoacidosis market.
Which Firms Dominate The Diabetic K*etoacidosis (DKA) Market Segments?
Major companies operating in the diabetic K*etoacidosis (DKA) market are Merck And Co. Inc., Pfizer Inc., Sanofi S.A., Bristol Myers Squibb, Novartis AG, Roche Holding AG, GlaxoSmithKline plc, Eli Lilly and Company, Boehringer Ingelheim International GmbH, Novo Nordisk A/S, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., B. Braun Medical Inc., Fresenius Kabi, Merit Pharmaceutical, Oramed Pharmaceuticals Inc., ICU Medical Inc., Tonghua Dongbao Pharmaceutical Co. Ltd., Wockhardt Ltd., Biocon Limited
What Diabetic K*etoacidosis (DKA) Market Trends Are Gaining Traction Across Different Segments?
Key businesses in the diabetic K*etoacidosis market are prioritizing the development of groundbreaking technologies like continuous glucose monitor tools. These tools enhance early detection and efficient management of blood glucose and k*etone levels, and ultimately, lower the frequency and seriousness of DKA episodes in diabetes patients. Continuous glucose monitor (CGM) devices constantly measure glucose levels in the body, providing data in real-time, which helps diabetes patients control their blood glucose levels. For instance, Abbott Laboratories, a US-based medical device producer, introduced new continuous glucose-k*etone monitoring systems in June 2022, delivering real-time observations of both glucose and k*etone levels. This system offers a complete overview of a patient's metabolic status by tracking glucose and k*etones simultaneously. It aids in early identification of potential diabetic risks like diabetic K*etoacidosis (DKA), before they exacerbate. The system is engineered for continuous observation, granting users continuous and common data updates without the necessity for manual testing.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/diabetic-K*etoacidosis-dka-global-market-report
Which Is The Largest Region In The Diabetic K*etoacidosis (DKA) Market?
North America was the largest region in the diabetic K*etoacidosis (DKA) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the diabetic K*etoacidosis (DKA) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Diabetic K*etoacidosis (DKA) Market?
2. What is the CAGR expected in the Diabetic K*etoacidosis (DKA) Market?
3. What Are the Key Innovations Transforming the Diabetic K*etoacidosis (DKA) Industry?
4. Which Region Is Leading the Diabetic K*etoacidosis (DKA) Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
The Business Research Company provides in-depth research and insights through a vast collection of 15,000+ reports spanning 27 industries and over 60 geographies. Backed by 1,500,000 datasets, extensive secondary research, and expert insights from industry leaders, we equip you with the knowledge needed to stay ahead in the market.
Our flagship offering, the Global Market Model, is a leading market intelligence platform that delivers comprehensive and up-to-date forecasts to support strategic decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Diabetic K*etoacidosis (DKA) Market Size Forecasted To Achieve 4.37 Billion By 2029 With Steady Growth here
News-ID: 4069673 • Views: …
More Releases from The Business Research Company
Leading Companies Reinforce Their Presence in the Blanket Market
The blanket market is steadily gaining traction as consumers increasingly seek comfort and style in their home essentials. With evolving preferences and technological advancements, this sector is set to experience consistent growth. Let's explore the current market value, key players, emerging trends, and the main segments fueling this expansion.
Forecasted Blanket Market Size and Growth Trajectory
The blanket market has seen consistent growth over recent years. From a market size…
Global Trends Review: The Rapid Evolution of the Sporting and Athletic Goods Mar …
The sporting and athletic goods market is experiencing steady growth, driven by evolving consumer preferences and technological advancements. As health and wellness continue to gain importance globally, this market is set for notable expansion in the coming years. Let's explore the current market size, key factors fueling its growth, leading companies, major trends, and segmentation details.
Forecast for Sporting and Athletic Goods Market Size Through 2029
The sporting and athletic…
Train Seat Market Overview, Key Growth Factors, and Insights on Top Players
The train seat industry is experiencing notable growth, driven by advancements in technology and increasing demand for improved passenger comfort. As rail travel evolves, so does the need for innovative, efficient, and adaptable seating solutions that cater to modern requirements. Let's explore the current market status, key players, trends, and segments shaping the future of train seating.
Train Seat Market Size and Growth Expectations
The train seat market has seen…
Leading Companies Solidifying Their Presence in the Spunbond Nonwovens Market
The spunbond nonwovens industry has been experiencing notable growth and shows promising prospects for the coming years. This expanding market is being driven by several innovations and increasing demand across diverse sectors, signaling a robust future.
Projected Growth and Market Size of the Spunbond Nonwovens Market
The spunbond nonwovens market has demonstrated solid expansion recently, with its size expected to rise from $15.57 billion in 2024 to $16.59 billion in…
More Releases for DKA
European Diabetic Treatment Market Market Outlook 2025-2035: Key Developments an …
The European diabetic (DKA) treatment market is projected to experience stable mid-single-digit annual growth from 2025 to 2035, supported by rising diabetes prevalence, modernized emergency-care infrastructure, and the ongoing expansion of insulin and acute-care therapy capabilities. Based on aggregated market-assessment methodologies commonly used in the healthcare sector - including hospital expenditure mapping, insulin-usage modeling, and acute-care treatment-bundle valuation - the region's DKA treatment segment is estimated to represent a little…
Hyperglycemia Clinical Market to Reach USD 24.9 Billion by 2030
The Global Hyperglycemia Clinical Market is expanding rapidly as healthcare systems respond to rising diabetes prevalence, acute hyperglycemia episodes, and increased demand for real-time glucose monitoring and insulin management. According to Exactitude Consultancy, the market is projected to grow from USD 14.5 billion in 2023 to USD 24.9 billion by 2030, at a strong CAGR of 8.6%.
The market includes diagnostics, CGM devices, insulin delivery systems, emergency care drugs, hospital-based monitoring…
Diabetic acidosis (DKA) Market to Exceed USD 3.1 Billion by 2034
Diabetic acidosis (DKA) is a life-threatening complication of diabetes mellitus, primarily associated with type 1 diabetes but increasingly observed in poorly controlled type 2 diabetes patients. It occurs when the body produces high levels of due to insufficient insulin, leading to hyperglycemia, dehydration, and metabolic acidosis. Immediate medical intervention with insulin, fluid replacement, and electrolyte therapy is essential to prevent severe outcomes.
Download Full PDF Sample Copy of Market Report @…
Impact Of Rising Obesity Rates On The Expansion Of The Market: A Key Factor Shap …
How Are the key drivers contributing to the expansion of the diabetic ket*oacidosis (dka) market?
The rising prevalence of obesity is also driving the expansion of the diabetic ket*oacidosis (DKA) market. Obesity is linked to insulin resistance and type 2 diabetes, which can trigger severe complications such as DKA, a potentially life-threatening condition. As obesity rates rise globally-the World Health Organization (WHO) reported that one in eight people worldwide struggled with…
Diabetic acidosis Treatments Market Growth, Segmentation, and Forecast Analysis …
Diabetic acidosis Treatments Market Snapshot: Insight into Market Trends and Movements
Diabetic acidosis (DKA) treatments include insulin administration, fluid replacement, electrolyte management, and monitoring blood glucose levels. The Diabetic acidosis Treatments market is experiencing significant growth, propelled by an increase in diabetes prevalence and the rising awareness of DKA complications. Innovations in treatment protocols, especially in insulin delivery systems and continuous glucose monitoring, are shaping market dynamics. The…
Diabetic Ketoacidosis Treatment Market Scenario – The Competition Is Rising | …
Diabetic Ketoacidosis Treatment Market:
The global diabetic Ketoacidosis treatment market is valued at USD 1,256.96 million in 2019, growing at a CAGR of 6.1% during the forecast period of 2017-2029.
Diabetic Ketoacidosis (DKA) is characterized by excessive ketone acid accumulation in the bloodstream due to the insulin shortage in the body. A Severe hyperglycemic emergency in diabetic patients leads to a substantial increase in blood sugar level that disturbs the balance between insulin level…
